Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate
Dexmedetomidine is an 𝛼2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe t...
Main Authors: | Bryan A. Max, Keira P. Mason |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | International Journal of Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2010/825079 |
Similar Items
-
Cardiovascular effects of dexmedetomidine constant rate infusion in anesthetized dogs
by: Hsin-Cheng Pan, et al.
Published: (2018) -
Dexmedetomidine: What’s New for Pediatrics? A Narrative Review
by: Mohamed Mahmoud, et al.
Published: (2020-08-01) -
Use of dexmedetomidine infusion in anaesthesia for awake craniotomy
by: Basavaraj G Kallapur, et al.
Published: (2012-01-01) -
Severe Hypertension with Dexmedetomidine Infusion during Awake Craniotomy
by: Suman Sokhal, et al.
Published: (2018-01-01) -
Laparoscopic appendectomy under spinal anesthesia with dexmedetomidine infusion
by: Go-Woon Jun, et al.
Published: (2014-10-01)